Talkzone

September 22, 2018

Car T-Cell Therapy

Episode Segments

Mayo Clinic Radio: Chimeric antigen receptor T-cell therapy

CAR T-cell therapy begins by collecting a patient’s white blood cells (T-cells) and sending them to a central manufacturing facility, where they are genetically modified to direct them against a patient’s cancer. Once processed, the CAR T-cells are frozen and sent back to the hospital for IV infusion back into the patient.